Your World, Fully Explored.
Published loading...Updated

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

Summary by MedPage Today
(MedPage Today) -- SAN FRANCISCO -- A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...

19 Articles

All
Left
Center
6
Right
Science DailyScience Daily
+2 Reposted by 2 other sources
Center

Researchers develop method to identify dormant cells that carry HIV

Study findings provide a new gene pathway for potential treatment of the virus affecting millions.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

theliberationnews.ng broke the news in on Wednesday, March 12, 2025.
Sources are mostly out of (0)